Islet cell transplantation
Islet cell transplantation is a type of cell therapy that involves the transplantation of Islets of Langerhans (clusters of cells from the pancreas) into a person who has Type 1 diabetes. This procedure is performed with the aim of restoring the body's ability to produce and regulate insulin, thereby improving blood glucose control and reducing the risk of diabetes-related complications.
Procedure[edit | edit source]
The procedure for islet cell transplantation involves isolating islet cells from a donor pancreas and then injecting these cells into the recipient's liver. The islet cells are usually infused into the portal vein, which carries blood to the liver. Once in the liver, the islet cells begin to produce and release insulin.
Benefits[edit | edit source]
The primary benefit of islet cell transplantation is the potential for improved blood glucose control, which can reduce the risk of diabetes-related complications such as kidney disease, heart disease, and neuropathy. In some cases, islet cell transplantation may allow individuals with type 1 diabetes to stop or reduce their insulin therapy.
Risks and Complications[edit | edit source]
Like all transplant procedures, islet cell transplantation carries certain risks. These include the risk of infection, bleeding, and blood clots. There is also the risk that the transplanted islet cells will not function as expected, or that the body will reject them. To reduce the risk of rejection, recipients of islet cell transplants must take immunosuppressive drugs, which can have side effects.
Research and Future Directions[edit | edit source]
Research into islet cell transplantation is ongoing, with scientists exploring ways to improve the effectiveness of the procedure and reduce the associated risks. One area of research involves the development of new methods for isolating and preparing islet cells for transplantation. Another area of research focuses on finding ways to protect transplanted islet cells from the immune system, potentially reducing the need for immunosuppressive drugs.
See Also[edit | edit source]
 | This medical article is a stub. You can help WikiMD by expanding it. |
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
